These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 226907)

  • 21. EEG and behavioral effects of ethylketocyclazocine, morphine and cyclazocine in rats: differential sensitivities towards naloxone.
    Tortella FC; Cowan A; Adler MW
    Neuropharmacology; 1980 Sep; 19(9):845-50. PubMed ID: 6106909
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioural effects in rats of unilateral and bilateral injections of opiate receptor agonists into the globus pallidus.
    Dewar D; Jenner P; Marsden CD
    Neuroscience; 1985 May; 15(1):41-6. PubMed ID: 2989729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opiate-receptor mediated changes in monoamine synthesis in rat brain.
    Garcia-Sevilla JA; Ahtee L; Magnusson T; Carlsson A
    J Pharm Pharmacol; 1978 Oct; 30(10):613-21. PubMed ID: 30814
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of ethylketocyclazocine on behaviors in mice using multi-dimensional behavioral analyses.
    Ukai M; Kameyama T
    Pharmacol Biochem Behav; 1987 Sep; 28(1):43-6. PubMed ID: 2821561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.
    Jackson A; Cooper SJ
    Psychopharmacology (Berl); 1988; 94(2):248-53. PubMed ID: 2895484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1984 Mar; 49():121-7. PubMed ID: 6090915
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of opioid receptors in shaking behaviour induced by paraquat in rats.
    Hara S; Iwata N; Kuriiwa F; Kano S; Kawaguchi N; Endo T
    Pharmacol Toxicol; 1993 Sep; 73(3):146-9. PubMed ID: 8265517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-allylnormetazocine (SKF-10,047): the induction of feeding by a putative sigma agonist.
    Gosnell BA; Levine AS; Morley JE
    Pharmacol Biochem Behav; 1983 Nov; 19(5):737-42. PubMed ID: 6316372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
    Heath RG; Fitzjarrell AT; Walker CF
    Biol Psychiatry; 1984 Jul; 19(7):1045-74. PubMed ID: 6089918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple opioid receptors.
    Iwamoto ET; Martin WR
    Med Res Rev; 1981; 1(4):411-40. PubMed ID: 6287130
    [No Abstract]   [Full Text] [Related]  

  • 31. Kappa opioid receptor-mediated analgesia in the developing rat.
    Barr GA; Paredes W; Erickson KL; Zukin RS
    Brain Res; 1986 Oct; 394(2):145-52. PubMed ID: 3021285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a kappa receptor agonist, ethylketocyclazocine, on water consumption in water-deprived and nondeprived rats in diurnal and nocturnal tests.
    Turkish S; Cooper SJ
    Pharmacol Biochem Behav; 1984 Jul; 21(1):47-51. PubMed ID: 6087378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mu-opioid component of the ethylketocyclazocine (EKC) discriminative stimulus in the rat.
    Locke KW; Gorney B; Cornfeldt M; Fielding S
    Psychopharmacology (Berl); 1989; 99(4):492-6. PubMed ID: 2556726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys.
    Tang AH; Collins RJ
    Psychopharmacology (Berl); 1985; 85(3):309-14. PubMed ID: 3923516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An in vivo pharmacological analysis of benzomorphan binding sites in rats.
    Cowan A; Gmerek DE
    NIDA Res Monogr; 1984 Mar; 49():114-20. PubMed ID: 6090914
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma corticosterone changes in response to central or peripheral administration of kappa and sigma opiate agonists.
    Eisenberg RM
    J Pharmacol Exp Ther; 1985 Jun; 233(3):863-9. PubMed ID: 2989500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3.
    Pechnick R; George R; Poland RE
    J Pharmacol Exp Ther; 1985 Jan; 232(1):170-7. PubMed ID: 2981314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine responses to benzomorphans (cyclazocine, ketocyclazocine and WIN 35, 197-2) in the rat.
    Murray GM; Kasson B; Garcia JA; George R
    Proc West Pharmacol Soc; 1978; 21():371-5. PubMed ID: 693519
    [No Abstract]   [Full Text] [Related]  

  • 39. Demonstration of opiate receptor sub-types in vivo.
    Rosenbaum JS; Sadée W
    Life Sci; 1982 Sep 20-27; 31(12-13):1299-301. PubMed ID: 6292617
    [No Abstract]   [Full Text] [Related]  

  • 40. Activation of locus coeruleus neurons in the rat by a benzazocine derivative (UM 1046) that mimics opiate withdrawal.
    Valentino RJ; Aston-Jones G
    Neuropharmacology; 1983 Dec; 22(12A):1363-8. PubMed ID: 6686652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.